Editorial: Integrative Cancer Treatment in the 21st Century Every discipline faces historical moments during its journey, and the field of integrative cancer care is no exception. For more than 2 decades, a small group of medical practitioners, walking a tightrope between overly rigid conventional approaches and overzealous alternative approaches to cancer care, has been working diligently and often independently to help shape and form an innovative approach to aid the patient confronted with cancer. While critical sparks flew from the extremes of both camps, distorting and diminishing each other's value, a new discipline was being born. Early on it was unclear exactly what the discipline would look like. Would it focus more on body or mind, supplements or medicines, surgery or meditation ? But in the last throes of labor when the field was crowning, a sensible, almost unarguable middle ground emerged. Slowly and methodically, with clinical care and research as the linchpin, this middle ground began taking form as the optimal ground. For patients in search of a broader array of therapies, active engagement in their own care, and a life-affirming approach provided by scientifically rigorous caregivers, hope and a new wave of cancer care had been born.
For these 20 plus years, since early in the inception of this work, I have kept a plaque of Schopenhauer's 3 stages of truth sitting on my desk, summarizing the genesis of every pioneering discipline: first, it is ignored; second, it is violently opposed; third, it is accepted as self-evident. Although we could debate at what stage integrative care now finds itself, with the publication of this, the first issue of Integrative Cancer Therapies, a peer-reviewed academic and professional journal, integrative care most certainly has arrived.
Along with a growing cadre of scientific and clinical experts, I believe that integrative therapy will rapidly command an important position in cancer medicine. But my belief goes a step further. I hold that integrative cancer care will be the future standard of all cancer medicine for the following reasons: integrative care has a commonsense potential for mitigating toxicity, it involves a more prominent recognition of the patient's needs as a fundamental of care, and it provides for enhanced outcomes due to multidimensional treatments with inherent synergisms (i.e., coupling mainstream modalities with selective integrative interventions). Thus, it is logical to position integrative cancer care as the benchmark against which limited cancer approaches can be compared. While all good medicine is patient focused, a basic tenet of this new wave of care is committing to and advocating patients' needs first. But as essential as this is to the underlying core, a focus on healing of the spirit and a schema that aims to enhance quality of life do not supercede improving health outcomes. I cannot stress this enough. Those of us who have put the greatest effort in helping to develop the clinical treatments and research needed to propel this burgeoning field forward know that, with time, we will be able to demonstrate its exciting impact on survival of many malignancies.
By recognizing the inherent value of conventional, experimental, complementary, traditional (non-Western medical practices), and alternativet practices, integrative care eliminates the unnecessary and artificial distinctions between these seemingly independent approaches to patient care. Integrative treatment methods are based on specific evidence and scientific understanding of the mechanisms of therapies and the physiology of disease conditions, while honoring psychosocial and spiritual needs. Integrative care can also be thought of as the combination of leading-edge conventional therapy with scientifically rigorous complementary and alternative medicine.
However, I choose the term integrative rather than integrated care in order to go an important step further. Whereas integrated care implies simply placing different practices alongside each other, integrative care implies an aim to weave practices together into a whole that is greater than the sum of its parts. In addition, integrative care demands a synthesis of relevant treatments actively brought together with attention to the patient's whole being, labs, psyche, soma, and other treatments, and it recognizes and takes advantage of their effects on one another. Although a bold undertaking, integrative care aims to treat the patient as a unified whole, promoting integration of body and biology, mind and spirit, nutrients and drugs. So why do I believe integrative care is the medicine of the future? First, patients are already tenaciously practicing it. In fact, it is so much a part of the wants and wishes of a growing number of patients that they are pursuing this kind of cancer care often in the face of disapproving providers. They are demanding a tAlternative in this context means responsible use of reasonable modalities that contain some logical and scientific undergirding. comprehensive approach to combating their illness. Cancer patients vote with their feet: they visit integrative, complementary, and alternative practitioners; they study, self-prescribe, and take supplements; they adhere to various systems from meditation and yoga to qi gong and shiatsu-and often combine any and all of these. Unfortunately, they do not often inform their oncologists. This in itself poses numerous potential risks as medical practitioners and other caregivers may operate without knowledge of potential interactive effects-some positive, some negative-between a range of different modalities. Second, integrative care makes solid scientific sense. A flood of evidence at all levels is accumulating in support of many integrative interventions. These interventions can include lower fat and high omega 3 fatty acid diets that retard the inflammatory cascade, and exercise systems responsible for improving quality of life in chemotherapy patients, in addition to psychological interventions associated with more favorable prognoses and better responses to treatment. Third, integrative care is the medicine of the future because it is an eminently sensible combination of scientific rigor with clinical pragmatism, even clinical wisdom. There are large databases filled with pragmatic observations of traditional systems of medicine. There are also an increasing number of experienced alternative and integrative practitioners who have the intellectual honesty to submit their empirical systems to scientific trial.
A good rule in scientific inquiry and clinical medicine, when the luxury of time is on one's side, is to peer back before leaping forward. In looking back at some aspects of my own journey in cancer and integrative medicine, I find some experiences of value that seem to reflect the evolution of the field itself. In 1980, while completing my training, I received the affectionate nickname &dquo;Dr. Sprouts&dquo; from my fellow residents.
When I was scheduled to lecture, the blackboard would read, &dquo;Dr. Sprouts is presenting today.&dquo; I acquired this label due to my advocacy of a whole-foods diet. But whereas my colleagues questioned the value of my diet-deeming it a harmless and insignificant aberration-they never questioned the fractured nature of the medical system. There were certainly exceptions, but it seemed poignantly obvious to me: the system reduced patients to their diagnoses and rejected as irrelevant any intervention that was not a direct assault on the diseased portion of the patient's body. My personal experiences with illness and my earnest desire for maximizing my own health convinced me that, as in any complex system, the human organism is a whole organism and that it is only by treating the whole organism-the whole person-that we can control and overcome illness. This meant that I had to confront the disruptions to a patient's health wherever they occurred, be it in a specific organ or in the recesses of a patient's psyche or soul. Thus, my practice evolved as I evolved. I studied Chinese medicine and acupuncture, meditation and yoga, macrobiotic diet and intravenous nutrition. By addressing seemingly unrelated aspects of ill health-psychological factors, individual biochemical alterations, cardiovascular fitness levels, and dietary patterns-I found that patients could achieve significant improvements in overall well-being and in some cases reverse disease. Yes, it was &dquo;anecdotal&dquo; observation, but it mattered not. Patients felt better and their lives were more whole, fulfilled, and connected. And it was a start. An important one.
Whereas some early colleagues directed their integrative efforts to cardiac medicine or allergies, I found that integrative approaches were nowhere more valuable than in the area of cancer care. The causes of cancer are multifactorial and still unclear, but it is precisely its puzzling and complex biology that makes cancer an unparalleled disease to combat and so challenging to overcome. The treatments of cancer have relied exclusively on tumor-directed approaches, which, until a recent refocusing toward molecular markers, offered limited advantages in survival and quality of life. For those of us uncomfortable with what was an obvious dearth of clinical answers for patients confronted with metastatic disease, thinking integratively provided options and treatment considerations that had seemed mostly unavailable. As I and other practitioners began exploring and integrating the multifactored and multidimensional nature of the cancer problem, I found that viewing the disease through this very different prism presented new insights and possibilities and more comprehensive treatment strategies. Of equal importance, it provided a means and inspiration to deal in greater depth with nearly every aspect of our patients' health. It was only a matter of time before I began seeing firsthand the clinical fruits of my treating patients using this comprehensive dispensary.
As time passed, a growing number of dedicated and diverse practitioners joined us in our journey. There was a need to dismantle the sacred but imaginary barriers and divisions partitioning various medical and complementary specialties. To engage in clinical work with patients desiring survival and healing, first required an obliteration of the walls that isolate fields of clinical oncology, psychology, phytochemistry, anthropology, and other disciplines.
Along the way, a critical hurdle was reached. Validating what was being observed was a new and daunting challenge. Like most fields of medicine, integrative practice cannot yet claim to be fully &dquo;evidence based.&dquo; The tension between designing randomized controlled trials (RCTs) and providing clinical interventions with reasonable scientific background for life-threatening disease adds an edge to many professional discussions. This discussion takes on particular problems when one recognizes the considerable safety of most integrative modalities and the near impossibility of performing RCTs across the integrative spectrum. The sheer number of possible interventions from complementary, alternative, and experimental medicine, as well as the many decades it could take to complete such investigations, virtually guarantees that these tense discussions will persist for a very long time. Nonetheless, there are RCTs, and they are growing in number.
With these sometimes heated discussions comes the need for a vehicle of communication for the integrative cancer care community. With the far-thinking support of Sage Publications and a committed group of editors, we have brought together a publication that will spearhead and focus this new and growing movement in cancer treatment. Integrative Cancer Therapies will provide scientifically based information on the various therapeutic interventions-diet, lifestyle change, exercise, stress care, nutritional supplements, enzyme therapies, biofeedback, experimental vaccines, immunotherapies, chronochemotherapy, and others. The need for scientific information on the application of these interventions in cancer, even among practitioners who consider themselves purely conventional, is becoming more urgent as patients undertake to integrate their own care and as integrative centers appear in hospitals across the country.
Integrative Cancer Therapies is, then, dedicated to furthering the rational, scientifically based practice of integrative cancer care and to improving the quality and length of our patients' lives. The philosophy that informs integrative care-seeking a whole that is greater than the sum of its parts-will also inform thisjournal. It will seek to gather in one place the wisdom and work of those who concentrate on researching and implementing integrative interventions in the clinical setting for the benefit of other clinicians and the patients they care for. Thejournal will recognize, as does a truly rigorous approach to integrative medicine, that simply gathering a variety of techniques in one place without seeking the synergies among them-and evaluating their safety and reliability-is not enough and is no longer acceptable. Fostering communication between scientists and clinicians is another aim of this journal. The scientist, appropriately, maintains a questioning, criticizing, and doubting attitude toward new ideas in medical care. The clinician, equally appropriately, fosters an attitude of hope rather than doubt in his or her patients. Reconciling the stances of scientist and clinician in a single person remains a difficult problem; in this journal, we plan to provide a specific forum for the scientific approach, but we bear in mind that this is, in the end, ajournal for clinicians and for all integrative caregivers, a place to seek constructive answers-and hope.
Like most journals, Integratzve Cancer Therapies will publish a variety of peer-reviewed articles. Clinical studies are obviously the meat of any medical journal, and this issue features a trial focusing on the radioprotective effects of an antioxidant extract of mung bean in breast cancer patients from Tran Van Hien and colleagues in Vietnam. Integrative providers from a range of practices need systematic education in the science of the field, and we plan to address this need through scientific and educational reviews. This issue features a detailed scientific review by Jeanne Wallace on the role of the inflammatory cascade in cancer and how cyclooxygenase-2 inhibitors-both natural and pharmacological-might be used to address it. Educational reviews are also featured. Alastair Cunningham discusses therapeutic and programmatic approaches in the psychological treatment of cancer patients and reflects on the basic directions of research in psychooncology. Carole Schneider and colleagues describe the theoretical concerns and practical guidelines of an institutionally based exercise program for cancer patients. Additionally, Charlotte Gyllenhal and I have reviewed the pharmacological interactions of herbs and nutritional compounds with chemotherapies through the cytochrome P450 isoenzyme system.
Any integrative cancer clinic-and conventional clinics as well-must stress communication between different practitioners about specific patient cases. In hospitals, this generally occurs through meetings of the facility's tumor board. In this issue, we are launching the first journal-based Integrative Tumor Board, a unique project in which a variety of practitionersradiation and medical oncologists, surgeons, nutritionists, psychologists, naturopaths, dietitians, body workers, traditional medicine practitioners, and others-will all respond to case presentations submitted by physicians from integrative clinics. In this feature, we hope to foster knowledge and understanding of the treatment goals and strategies of different disciplines that must all learn to work together to promote full integrative care of the patient. Like any scientific approach, integrative care in its journey, thus far, has encountered rough waters in the form of controversies that pose treatment dilemmas for practitioners and raise anxiety among patients. Such controversies include questions of whether soy products may be used by breast cancer patients and the role of antioxidant supplements in chemotherapy and radiation therapy. We will address these in a feature called Point-Counter Point in which different researchers will be asked to give their opinions on controversial topics. In this issue we address the question of soy and breast cancer. Future issues will also include Patient Perspectives, a series of reviews of the science behind specific herbs, supplements, and techniques that are currently in use by patients. Clinical Corner articles will address emerging treatments and data that are important in routine clinical work. Research Briefings-short abstracts of research on a variety of specific topics-as well as case reports and Letters to the Editor will also appear. We do encourage you to regard this as your journal as well and alert us to topics, problems, and concerns that you face in your clinical work.
Because there was so little known a few decades ago about cancer and the myriad ways it affected patients, neither practitioners nor patients had much scientifically credible recourse beyond conventional therapies. Today, however, even practitioners who prefer to stay within the boundaries of conventional medicine have no choice but to respond to the torrent of materials being unearthed by patients themselves who are desperately searching for meaningful ways to confront t their life-threatening diseases. All of us need to explore and fit into our treatment plans new research in a variety of as-yet neglected areas: the potential impact of depression and anxiety on response to chemotherapy, the power of timing in both breast cancer surgery and in the delivery of chemotherapy, and the use of a wide variety of natural compounds to enhance treatment effectiveness and diminish side effects. In the field of integrative cancer therapy, our journey-and this journal-will lead us to improved care for our patients while bringing more scientific credibility to integrative treatment. As integrative care actually becomes the medicine of the future, our patients confronting cancer can look forward to longer and more fulfilling lives and to ever more humane, compassionate, and scientifically validated treatment. We are embarking on a journey that addresses the needs of patients at every level, from the biochemical and molecular to the spiritual. We may even find that these levels are not so far apart. 
